Biotech Scan

Scan

Biotech Scan

Scan symbols 32
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSPDHRDNADXCMEDITEXASGILDIBBILMNIONSISRGLEGNLLYMDTMRNANTLANVOPTGXRAREREGNRXRXSRPTTMOVRTXXBI
Watchlists 1
@biotech-scan
raw scan snapshot — prices as of scan date, not live 45 rows · screens, not recommendations superseded by2026-04-26-biotech-scanported fromresearch/classic/scans/_archive/2026-03-26-biotech-scan.mdscan slugbiotech-scansource typescan-archive

Deeply bifurcated: EXAS, PTGX, MRNA, SRPT running hard while NVO, LEGN, RXRX, BEAM, CRSP are in structural downtrends with death crosses and no floor in sight.

Price Table

Symbol Price RSI vs SMA20 7D% 30D% Trend
EXAS 104.91 75.5 +1.2% +1.1% +1.5% strong-up
SRPT 21.68 63.8 +24.2% +40.4% +29.4% up
PTGX 102.17 63.7 +5.8% +3.7% +11.0% strong-up
MRNA 53.57 57.3 +0.5% +2.7% 0.0% strong-up
BIIB 191.06 56.8 +2.6% +3.4% -0.4% strong-up
ALNY 328.16 53.2 +2.7% +5.7% -1.4% strong-down
EDIT 2.32 52.8 0.0% +1.8% +5.5% weak-up
NTLA 13.24 51.6 -1.1% +4.7% -3.9% strong-up
XBI 123.92 50.1 0.0% +3.1% -2.7% weak-down
REGN 756.73 49.1 -0.3% +1.6% -3.2% weak-down
ILMN 124.40 49.1 -0.3% +3.3% -7.5% weak-down
IONS 74.24 46.6 -0.1% +2.6% -8.5% weak-down
IBB 165.38 44.6 -1.4% +1.7% -5.6% weak-down
TMO 488.85 44.0 -0.4% +6.9% -6.1% down
VRTX 453.74 43.9 -3.0% +1.2% -8.7% weak-down
AMGN 353.16 42.2 -3.4% +0.8% -9.0% weak-down
LEGN 17.49 42.2 -4.7% -2.4% -8.0% strong-down
RARE 20.00 42.3 -6.2% -1.9% -14.5% strong-down
CRSP 47.55 41.1 -8.5% +0.9% -20.9% strong-down
DNA 6.41 40.8 -5.1% +14.2% -5.0% strong-down
DXCM 66.09 40.5 -3.2% -1.5% -10.0% strong-down
A 113.51 39.2 -1.1% +2.0% -6.5% strong-down
ABBV 211.11 39.3 -4.4% +0.0% -9.0% down
BMRN 55.55 39.0 -4.2% +1.2% -10.0% down
BEAM 23.62 38.2 -8.6% -7.0% -17.0% down
GILD 136.88 37.0 -4.5% -2.1% -7.6% weak-down
BNTX 87.46 36.7 -7.4% +0.6% -20.7% down
RXRX 3.15 35.0 -7.4% -2.8% -14.2% strong-down
ISRG 468.55 35.1 -3.4% -1.9% -6.9% strong-down
MDT 87.68 35.5 -2.7% +0.8% -10.2% down
DHR 188.03 33.6 -3.5% -0.3% -10.7% down
LLY 896.61 31.8 -7.2% +0.4% -14.8% weak-down
NVO 36.38 31.7 -3.7% -0.4% -2.9% strong-down

Tier Analysis

Overbought / Momentum (RSI 60+)

  • EXAS (75.5): Parabolic, +140% 1Y, 41% above SMA200, at 52wk high. Overbought but sector's strongest.
  • SRPT (63.8): +40% in 7D spike, but -69% 1Y and 71% off high. Violent bounce, not a reversal.
  • PTGX (63.7): Legitimate momentum: +109% 1Y, +39% vs SMA200, golden cross. Real runner.
  • BIIB (56.8): Strong-up, golden cross, +21% vs SMA200. Clean setup.
  • MRNA (57.3): +72% in 3M, 62% above SMA200, golden cross. mRNA trade is back.

Oversold (RSI < 35)

  • LLY (31.8): -14.8% in 30D, approaching SMA200 ($893). Golden cross. GLP-1 franchise at potential deep-value entry.
  • NVO (31.7): Death cross, -55% from high, -32.6% vs SMA200. Structurally broken.

Entry Zones

Stock Entry Range Thesis
LLY $880–900 Near SMA200 support. Golden cross. Confirmation: RSI bounce > 35.
PTGX Pullback to $96 Momentum continuation. +393% 3Y. Add at SMA20.
BIIB $183–186 Strong-up, golden cross, near SMA20 support.
MRNA Hold / wait Extended at +72% 3M. Let RSI consolidate.

Action Matrix

Symbol Action Rationale
EXAS Hold / trim RSI 75.5, overbought near 52wk high — wait for cooling
PTGX Buy dip Best sustained momentum; add at SMA20 ($96.55)
BIIB Buy Strong-up, golden cross, near SMA20 support
MRNA Hold Strong-up but extended
LLY Watch Approaching oversold near SMA200 — wait for reversal
NVO Avoid Death cross, -55% from high, no floor
CRSP/BEAM Avoid Gene editing in freefall: -21%/-17% 30D
RXRX/RARE/LEGN Avoid Death cross, deeply negative

What Changed

  • SRPT exploded +40.4% in 7D — catalyst event, but -69% 1Y; treat as noise
  • MRNA +72% in 3M with golden cross — mRNA rerating continues
  • BNTX -20.7% 30D while MRNA flat — mRNA pair trade diverging
  • LLY lost -14.8% in 30D — approaching decision point at SMA200
  • XBI/IBB holding RSI 44-50 — broad biotech hasn't broken despite individual carnage

Data: 2026-03-26 pre-computed summaries.

10 events
DateTypeEvent
Mar 20 ScanBiotech Scan Mar 12 ScanBiotech Scan Mar 11 ScanBiotech Scan Mar 10 ScanBiotech Scan Mar 24 ScanBiotech Scan Mar 13 ScanBiotech Scan Apr 26 ScanBiotech Scan Apr 28 ScanBiotech Scan Mar 31 ScanBiotech Scan May 29 ScanBiotech Scan

No direct external sources are attached to this read.